Sep 2 2022 10:01 am
The European Medicines Agency approved the BioNTech/Pfizer vaccine preparations adapted to the Omicron subvariant BA.1 on Thursday. According to Federal Health Minister Karl Lauterbach, these can be delivered as early as next week.
The European Medicines Agency EMA in Amsterdam on Thursday approved the BioNTech/Pfizer vaccines adapted to the omicron subvariant BA.1. These can now be vaccinated within the European Union. Currently, however, this sub-variant no longer plays a role. Approval is therefore more or less based on the hope that it will also work against the currently dominant subvariants. The EU Commission may want to accept the EMA recommendation very promptly. According to Federal Health Minister Karl Lauterbach (SPD), the adapted vaccines are to be delivered in Germany as early as next week.
The EMA is also examining the approval of mRNA vaccines that are adapted to the current omicron variants BA.4 and BA.5. According to a letter from Lauterbach, Germany could be supplied by BioNTech/Pfizer with a first tranche of 9.5 million doses if the EU Commission were to approve these vaccines at the end of September or beginning of October.
More on the subject – BioNTech boss Şahin: New Omicron vaccine could be delivered in early September